Article
Anaplastic lymphoma kinase as a new target for the treatment of non-small-cell lung cancer
1 Nov 2011
Abstract excerpt
The anaplastic lymphoma kinase (ALK) gene rearrangement identifies a distinct molecular subset in non-small-cell lung cancer (NSCLC) populations susceptible to targeted inhibition. It consists of a small inversion in the short arm of chromosome 2 between exon 20 of the ALK gene and different exons of the echinoderm microtubule-associated protein-like (EML4) gene. This translocation leads to a chimeric protein...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
